Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 14,510
-480 (-3.20%)
At close: May 29, 2026
Sam-A Pharm. Market Cap
Sam-A Pharm. has a market cap or net worth of 88.56 billion as of June 1, 2026. Its market cap has decreased by -14.14% in one year.
Market Cap
88.56B
Enterprise Value
-8.22B
Revenue
70.93B
Ranking
n/a
PE Ratio
9.97
Stock Price
14,510.00
Market Cap Chart
Since November 29, 2000, Sam-A Pharm.'s market cap has increased from 32.75B to 88.56B, an increase of 170.42%. That is a compound annual growth rate of 3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 88.56B | -7.64% |
| Dec 30, 2025 | 95.88B | -5.98% |
| Dec 30, 2024 | 101.99B | 1.89% |
| Dec 28, 2023 | 100.09B | -1.50% |
| Dec 29, 2022 | 101.62B | -13.95% |
| Dec 30, 2021 | 118.10B | 16.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 106.08B |
| KOREA PHARMA | 102.96B |
| Organoidsciences | 97.27B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Polaris AI Pharma | 89.13B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 77.22B |